Vice President, Clinical Development, I&I

The Company is seeking a Vice President of Clinical Development to provide medical and strategic leadership for its clinical portfolio. The role will lead clinical development strategy and execution for programs in ulcerative colitis and pulmonary indications, while providing additional support for a celiac disease program. Responsibilities include overseeing clinical studies, shaping future trial designs, reviewing and interpreting safety and efficacy data, and guiding clinical pharmacology, biomarker, and translational strategies. The Vice President will also lead clinical and regulatory document development, engage with investigators and health authorities, manage development risks and milestones, and contribute clinical insight to portfolio and business planning. Candidates must hold an M.D. or Ph.D.; board certification or advanced clinical training in gastroenterology is strongly preferred. Typically, at least 12 years of relevant biopharmaceutical clinical development experience is required, including meaningful leadership of immunology and inflammation programs. Demonstrated expertise in inflammatory bowel disease, particularly ulcerative colitis, is essential; experience in celiac disease, other immune-mediated gastrointestinal disorders, or pulmonary diseases is desirable. The ideal candidate is decisive, pragmatic, collaborative, and able to provide hands-on leadership in a fast-moving environment.